Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01568359 · ClinicalTrials.gov registry record
Calcium Homeostasis in Acromegaly: Effect of Surgical/Medical Treatment and Comparison With Nonfunctioning Pituitary Tumors
A clinical trial, sponsored by Emory University.
- Completed
- Registry status
- 49
- Enrollment target
NCT01568359 is a clinical trial that has completed, run by Emory University. The registered enrollment target is 49 participants.
The verdict
NCT01568359 has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- 49 participants
- Enrollment target
Study Summary
The purpose of the study is to evaluate the Calcium homeostasis in adult patients with uncontrolled acromegaly. The measurements will be repeated 3-6 months after the treatment of acromegaly (surgical or medical). The control group consists of patients with nonfunctioning pituitary tumors who will undergo surgical removal.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 49 participants |
| Start Date | 2011-12 |
| Est. Completion | 2014-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01568359
The ClinicalTrials.gov registry entry for NCT01568359 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 49 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01568359 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01568359 about?
NCT01568359 is a clinical study titled "Calcium Homeostasis in Acromegaly: Effect of Surgical/Medical Treatment and Comparison With Nonfunctioning Pituitary Tumors". The purpose of the study is to evaluate the Calcium homeostasis in adult patients with uncontrolled acromegaly. The measurements will be repeated 3-6 months after the treatment of acromegaly (surgical or medical). The control group consists of patients with nonfunctioning pituitary tumors who will u...
What is the current status of trial NCT01568359?
This trial is currently completed. The enrollment target is 49 participants. The study started on 2011-12. Estimated completion is 2014-08.
Who is sponsoring clinical trial NCT01568359?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.